Vivera Pharmaceuticals Congratulates Partner Clinical Research Organization, Parexel International, on $8.5 Billion Acquisition by Goldman Sachs
NEWPORT BEACH, Calif. – Vivera Pharmaceuticals, Inc., congratulates its clinical research partner, Parexel International, on its $8.5 billion acquisition. The EQT IX fund and the private equity business within Goldman Sachs Asset Management recently agreed to purchase the clinical research organization and biopharmaceutical company. Parexel is a leading global provider of clinical research and consulting […]
